Search
for
Sort by
Research 61–90 of 73
- Effect of palbociclib plus letrozole on patient-reported health-related quality of life: extended follow-up of the PALOMA-2 trial
- Safety and quality of life of CDK4/6 inhibitors therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: a multicenter cross-sectional survey in China
- Menopause and hair loss in women: Exploring the hormonal transition
- Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study
- Advancing PROTAC therapeutics through chemistry-guided design of smart delivery systems
- Cold Atmospheric Plasma for Breast Cancer
- Impact of Reporter Type on Signal Detection of Cancer Therapy-Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Impact of Reporter Type on Signal Detection of Cancer Therapy–Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Breast cancer in a transgender man
- Clinical and phototrichogrammatic evaluation of estradiol replacement therapy on hair growth in postmenopausal Japanese women with female pattern hair loss: a pilot study
- Estrogens
- ZALCITABINE
- Methods of treatment patients with androgenetic alopecia based on reference of Department of Dermatology in Cracow.
- Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
- Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies
- Oestrogen receptor antagonist and hair regrowth in dogs with hair cycle arrest (alopecia X)
- Real-World Safety Profile of Generic Palbociclib in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Prospective Observational Study in Iraq”
- Incidence of alopecia from endocrine therapies in cancer
- Onychomatricoma with classic features: Case report and review of the literature
- An estrogen receptor pathwayregulates thetelogen-anagen hair follicle transition andinfluences epidermal cell proliferation (epidermis/estrogen/keratinocyte/differentiation/mesenchymal
- Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinion
- Hormone Blocking Anticancer Drugs
- Minimal systemic exposure of a new topical triazole antifungal, efinaconazole 10% solution, in patients with severe onychomycosis following 28-day treatment
- Effect of estrogens on skin aging and the potential role of selective estrogen receptor modulators
- Female Pattern Hair Loss
- Interventions for female pattern hair loss
- Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS‐CoV‐2 in the respiratory tract
- Transcriptomics analysis reveals molecular alterations underpinning spaceflight dermatology